SI
ORIC icon

Sofinnova Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Sofinnova Investments’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.61M Buy
+679,578
New +$7.71M 0.33% 48
2020
Q3 		– Sell
-17,369
Closed -$585K – 81
2020
Q2 		$585K Buy
+17,369
New +$554K 0.04% 75

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Sofinnova Investments's ORIC Position: Q1 2026 in Review

Sofinnova Investments opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 679,578 shares worth $8.61M. The stake represents 0.33% of the portfolio and ranks #48 among its holdings. This is a return to the name: Sofinnova Investments previously reported a position in ORIC as recently as Q2 2020.

Sofinnova Investments first reported a position in ORIC in Q2 2020 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Sofinnova Investments held 679,578 shares of Oric Pharmaceuticals worth $8.61M as of Q1 2026.
  • Oric Pharmaceuticals was a new Sofinnova Investments position in Q1 2026.
  • Oric Pharmaceuticals made up 0.33% of Sofinnova Investments's portfolio in Q1 2026, its #48 holding.
  • Sofinnova Investments first reported a position in Oric Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.